Investigation of Naltrexone for Pathological Gambling
What is the purpose of this trial?
The investigators plan to investigate the safety, tolerability, and efficacy of the opioid antagonist naltrexone in Pathological Gambling. We hypothesize that naltrexone will be superior to placebo in reducing gambling urges and behavior, when combined with adjuvant non-pharmacological treatment as usual.
- 18 Years and older
- National Center for Responsible Gaming
- February 2009
- Last Updated:
- January 29, 2013
- Study HIC#:
Clinicaltrials.gov ID: NCT01057862